Intro: Peritoneal carcinomatosis due to gastric malignancy (GPC) responds inadequately to basic chemotherapy. Restrictedly distributed information shows better results. We studied the appropriateness of the medical procedure of cytoreduction (CRS) and hyperthermia intraperitoneal chemoperfusion (HIPEC) into GPC. Methods: Our current research was conducted at Jinnah Hospital, Lahore from March 2018 to February 2019. We have provisionally studied 28 patients with The CPG knows about CRS/HIPEC somewhere between March 2018 to February 2019. Kaplan-Meier and multivariate Cox endurance curves Relapse models have recognized prognostic elements that influence the oncology results. Results. The CRS/HIPEC remained conducted for GPC in 25 cases and...
Abstract Ashwin K.R. ...
Abstract: Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor ...
This thesis focuses on the treatment of peritoneal metastases of gastric and colorectal cancer, spec...
Peritoneal carcinomatosis (PC) from gastric cancer is a condition with a very bleak prognosis. Most ...
Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death in...
Peritoneal Carcinomatosis (PC) from metastasization of Gastric Cancer (GC), either present at first ...
Background: An increasing promising evidence and increasing long-term oncologic outcomes support the...
Hypothesis: The most common cause of palliative resection and recurrence in gastric cancer is perito...
Introduction: Intraperitoneal hyperthermic chemoperfusion has been proposed for treatment of perito...
The number of new gastric cancer (GC) cases is decreasing, and these patients have longer survival t...
BACKGROUND: Patients with gastric cancer and peritoneal carcinomatosis have a very poor prognosis; m...
Peritoneal carcinomatosis (PC) is a dismal feature of gastric cancer that most often is treated by s...
Background: The development of multimodality treatment, including cytoreductive surgery (CRS) with h...
Background: Our experience regarding cytoreductive surgery (CRS) and hyperthermic intraperitoneal ch...
Abstract Ashwin K.R. ...
Abstract: Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor ...
This thesis focuses on the treatment of peritoneal metastases of gastric and colorectal cancer, spec...
Peritoneal carcinomatosis (PC) from gastric cancer is a condition with a very bleak prognosis. Most ...
Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death in...
Peritoneal Carcinomatosis (PC) from metastasization of Gastric Cancer (GC), either present at first ...
Background: An increasing promising evidence and increasing long-term oncologic outcomes support the...
Hypothesis: The most common cause of palliative resection and recurrence in gastric cancer is perito...
Introduction: Intraperitoneal hyperthermic chemoperfusion has been proposed for treatment of perito...
The number of new gastric cancer (GC) cases is decreasing, and these patients have longer survival t...
BACKGROUND: Patients with gastric cancer and peritoneal carcinomatosis have a very poor prognosis; m...
Peritoneal carcinomatosis (PC) is a dismal feature of gastric cancer that most often is treated by s...
Background: The development of multimodality treatment, including cytoreductive surgery (CRS) with h...
Background: Our experience regarding cytoreductive surgery (CRS) and hyperthermic intraperitoneal ch...
Abstract Ashwin K.R. ...
Abstract: Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor ...
This thesis focuses on the treatment of peritoneal metastases of gastric and colorectal cancer, spec...